Close
CDMO Safety Testing 2026
Novotech

Press Releases

FedEx Marks Anniversary of First COVID-19 Vaccine Deliveries

One year ago, FedEx Express, a subsidiary of FedEx Corp and one of the worldโ€™s largest express transportation companies, delivered the first shipments of the COVID-19 vaccines to dosing centers in the United States. The day marked a turning...

Peli BioThermal Offers On Demand InnovationShare Webinars

Peli BioThermal, the global name in temperature controlled packaging solutions, recently concluded its 2021 webinar series. InnovationShare, launched in March 2021, focuses on best practices in clinical and commercial supply chain management. The series helped fill the in-person learning...

HiRO and CluePoints Partnership Offers Market-Leading RBQM Opportunities in China

Harvest Integrated Research Organization (HiRO), a Shanghai-based Clinical Research Organization (CRO), has collaborated with CluePoints, the premier provider of Risk-Based Study Execution (RBx) and Data Quality Oversight Software, to provide Risk-Based Quality Management (RBQM) expertise and technology in the...

Moderna COVID-19 Vaccine Manufactured in Korea by Samsung Biologics Receives Marketing Authorization from MFDS

Moderna, a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the Ministry of Food and Drug Safety of Korea (MFDS) has issued a marketing authorization for Spikevaxยฎ, Moderna's COVID-19 vaccine (mRNA-1273) manufactured by Samsung Biologics, a...

Pfizer and BioNTech Receive U.S. FDA Emergency Use Authorization of COVID-19 Vaccine Booster for Individuals 16 Years and Older

Pfizer Inc. and BioNTech SE announced that the U.S. FDA has expanded the Emergency Use Authorization (EUA) of a booster dose of the Pfizer-BioNTech COVID-19 vaccine to include individuals 16 years of age and older. The booster dose is...

Lilly and Regor Therapeutics Group Enter into Strategic Collaboration to Discover and Develop Novel Therapies for Metabolic Disorders

Eli Lilly and Company and Regor Therapeutics Group have entered into a multi-year research collaboration and licensing agreement to discover, develop and commercialize novel therapies for metabolic disorders. Under the terms of the agreement, Lilly will have a license to...

Actemra/RoActemra approved by the European Commission to treat patients with severe COVID-19

Roche announced that the European Commission has extended the marketing authorisation for Actemraยฎ/RoActemraยฎ (tocilizumab) to include the treatment of COVID-19 in adults who are receiving systemic corticosteroids and require supplemental oxygen or mechanical ventilation.1 This decision comes just hours...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read

Translate ยป